CLINICAL_TRIALS
research
· 2026-01-26
Clinical Trial Update: Escitalopram in Asthma Patients With Frequent Exacerbation [Phase 2]
Summary
A Phase 2 clinical trial is evaluating escitalopram for asthma patients with frequent exacerbations and is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Texas Southwestern Medical Center | Conditions: Asthma | Phase 2 | Status: RECRUITING